← Leaderboards
Alan L Schneyer
Massachusetts General Hospital
$6,855,017
Attributed
$6,855,017
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $920.2K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,855,017 · 8
By mechanism
R01$4,059,792 · 3
U54$1,219,334 · 1
R44$920,248 · 1
R21$449,542 · 1
R43$192,101 · 1
R56$14,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- David Pepin$2,535,692
- Joel S Finkelstein$18,947,740
- Jason David Roh$2,371,621
- Masao Kaneki$4,766,521
- Corrine K Welt$6,308,123
Others in their field
Top investigators on “Follistatin”
- Martin M Matzuk · University Of Missouri-Columbia$10,325,184
- Nikolaos G Frangogiannis · Albert Einstein College Of Medicine$7,727,341
- Morris F. White · Boston Children'S Hospital$6,443,756
- Pamela L Mellon · University Of California San Diego$6,147,317
- Se-Jin Lee · Johns Hopkins University$5,132,126
- Kenneth Walsh · Tufts University Boston$5,124,546
Research focus
FollistatinInhibinCell LineHormone Regulation /Control MechanismGraafian FolliclesFertilityFemaleGranulosa CellLeadRegulationActivinsMouse ModelCell ProliferationFertilizationClinical ResearchAdultInfertilityGrowthFailure (Biologic Function)BiologicalBirthBiochemicalGenesDefect
Grant awards (25)
Development Of Novel Diabetes Therapies Based On Neutralizing FSTL3 Activity$920,248
R44 · FY2018 · DK · contact PI
Development Of Novel Diabetes Therapies Based On Neutralizing FSTL3 Activity$192,101
R43 · FY2016 · DK · contact PI
Regulation Of Follicle Development and Fertility By Activin and Follistatin$193,799
R21 · FY2011 · HD · contact PI
Regulation Of Follicle Development and Fertility By Activin and Follistatin$255,743
R21 · FY2010 · HD · contact PI
Physiologic Roles of Activin and Myostatin Antagonists$88,765
R01 · FY2010 · DK · contact PI
Physiologic Roles of Activin and Myostatin Antagonists$221,240
R01 · FY2009 · DK · contact PI
Physiologic Roles of Activin and Myostatin Antagonists$222,793
R01 · FY2008 · DK · contact PI
Physiologic Roles of Activin and Myostatin Antagonists$241,063
R01 · FY2007 · DK · contact PI
Physiologic Roles of Activin and Myostatin Antagonists$14,000
R56 · FY2006 · DK · contact PI
Physiology &Action of a New Follistatin-Related Protein$381,366
R01 · FY2005 · HD
Physiology &Action of a New Follistatin-Related Protein$381,366
R01 · FY2004 · HD
MECHANISM AND REGULATION OF FOLLISTATIN PROCESSING$294,015
R01 · FY2004 · DK
Physiology &Action of a New Follistatin-Related Protein$381,366
R01 · FY2003 · HD
MECHANISM AND REGULATION OF FOLLISTATIN PROCESSING$285,452
R01 · FY2003 · DK
Physiology &Action of a New Follistatin-Related Protein$381,366
R01 · FY2002 · HD
MECHANISM AND REGULATION OF FOLLISTATIN PROCESSING$278,933
R01 · FY2002 · DK
ROLE OF INTRAFOLLICULAR ACTIVIN AND FOLLISTATIN IN PCOS$236,078
U54 · FY2002 · HD
ROLE OF INTRAFOLLICULAR ACTIVIN AND FOLLISTATIN IN PCOS$236,078
U54 · FY2002 · HD
Physiology &Action of a New Follistatin-Related Protein$364,284
R01 · FY2001 · HD
MECHANISM AND REGULATION OF FOLLISTATIN PROCESSING$269,067
R01 · FY2001 · DK
ROLE OF INTRAFOLLICULAR ACTIVIN AND FOLLISTATIN IN PCOS$236,078
U54 · FY2001 · HD
ROLE OF INTRAFOLLICULAR ACTIVIN AND FOLLISTATIN IN PCOS$230,631
U54 · FY2001 · HD
ROLE OF INTRAFOLLICULAR ACTIVIN AND FOLLISTATIN IN PCOS$280,469
U54 · FY2000 · HD
MECHANISM AND REGULATION OF FOLLISTATIN PROCESSING$268,716
R01 · FY2000 · DK
ROLE OF INTRAFOLLICULAR ACTIVIN AND FOLLISTATIN IN PCOS$0
U54 · FY2000 · HD